JP2021501201A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021501201A5 JP2021501201A5 JP2020543254A JP2020543254A JP2021501201A5 JP 2021501201 A5 JP2021501201 A5 JP 2021501201A5 JP 2020543254 A JP2020543254 A JP 2020543254A JP 2020543254 A JP2020543254 A JP 2020543254A JP 2021501201 A5 JP2021501201 A5 JP 2021501201A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- polypeptide conjugate
- staple
- amino acid
- conjugate according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023115915A JP2023134675A (ja) | 2017-10-27 | 2023-07-14 | ステープルペプチドの細胞内送達のためのポリペプチド接合体 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762578213P | 2017-10-27 | 2017-10-27 | |
| US62/578,213 | 2017-10-27 | ||
| PCT/US2018/057894 WO2019084528A1 (en) | 2017-10-27 | 2018-10-28 | POLYPEPTIDE CONJUGATES FOR INTRACELLULAR ADMINISTRATION OF STAPLED PEPTIDES |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023115915A Division JP2023134675A (ja) | 2017-10-27 | 2023-07-14 | ステープルペプチドの細胞内送達のためのポリペプチド接合体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021501201A JP2021501201A (ja) | 2021-01-14 |
| JP2021501201A5 true JP2021501201A5 (cg-RX-API-DMAC7.html) | 2021-12-09 |
| JP7780253B2 JP7780253B2 (ja) | 2025-12-04 |
Family
ID=66247031
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020543254A Active JP7780253B2 (ja) | 2017-10-27 | 2018-10-28 | ステープルペプチドの細胞内送達のためのポリペプチド接合体 |
| JP2023115915A Pending JP2023134675A (ja) | 2017-10-27 | 2023-07-14 | ステープルペプチドの細胞内送達のためのポリペプチド接合体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023115915A Pending JP2023134675A (ja) | 2017-10-27 | 2023-07-14 | ステープルペプチドの細胞内送達のためのポリペプチド接合体 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US11510991B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3700548A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7780253B2 (cg-RX-API-DMAC7.html) |
| CN (2) | CN117567639A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3080617A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019084528A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019070962A1 (en) | 2017-10-04 | 2019-04-11 | Ohio State Innovation Foundation | BICYCLIC PEPTIDE INHIBITORS |
| WO2019084528A1 (en) * | 2017-10-27 | 2019-05-02 | Ohio State Innovation Foundation | POLYPEPTIDE CONJUGATES FOR INTRACELLULAR ADMINISTRATION OF STAPLED PEPTIDES |
| WO2019148195A2 (en) | 2018-01-29 | 2019-08-01 | Ohio State Innovation Foundation | Cyclic peptidyl inhibitors of cal-pdz binding domain |
| WO2021041895A1 (en) * | 2019-08-30 | 2021-03-04 | Ohio State Innovation Foundation | Stapled beta-catenin ligands |
| CN112245593B (zh) * | 2020-10-30 | 2022-05-13 | 西南交通大学 | 具有疏水性侧链的稳定化细胞穿膜肽及制备方法与应用 |
| JP2024522368A (ja) * | 2021-06-08 | 2024-06-18 | フォグ ファーマシューティカルズ， インコーポレイテッド | ステープルペプチドおよびその方法 |
| IL314036A (en) | 2022-01-06 | 2024-09-01 | Oak Crest Inst Of Science | Subdermal implant for sustained drug delivery |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1133317A1 (de) | 1998-11-26 | 2001-09-19 | Pentapharm AG | Transportsystemkonjugate |
| US7033597B2 (en) | 2000-10-13 | 2006-04-25 | Université de Lausanne | Intracellular delivery of biological effectors |
| JP4387669B2 (ja) | 2000-10-13 | 2009-12-16 | ザイジェン エス．アー． | 新規なトランスポーターペプチド配列による生物学的エフェクターの細胞内送達 |
| CN112500466B (zh) | 2012-02-15 | 2022-05-03 | 艾瑞朗医疗公司 | 拟肽大环化合物 |
| WO2013150338A1 (en) * | 2012-04-04 | 2013-10-10 | Centre National De La Recherche Scientifique | Stapled cell penetrating peptides for intracellular delivery of molecules |
| EP2873678B8 (en) * | 2012-07-11 | 2024-07-17 | Gemvax & Kael Co., Ltd. | Conjugate comprising a cell-penetrating peptide and compositions comprising same |
| WO2015148620A2 (en) * | 2014-03-25 | 2015-10-01 | University Of Utah Research Foundation | Peptide inhibitors of bcr-abl oligomerization |
| WO2015153761A2 (en) | 2014-04-02 | 2015-10-08 | University Of Rochester | Macrocyclic peptidomimetics for alpha-helix mimicry |
| US10815276B2 (en) | 2014-05-21 | 2020-10-27 | Entrada Therapeutics, Inc. | Cell penetrating peptides and methods of making and using thereof |
| PL3149025T3 (pl) | 2014-05-21 | 2019-11-29 | Entrada Therapeutics Inc | Peptydy penetrujące komórkę i sposoby ich wytwarzania i stosowania |
| GB2545898B (en) | 2015-12-21 | 2019-10-09 | Sutura Therapeutics Ltd | Improved drug delivery by conjugating oligonucleotides to stitched/stapled peptides |
| US20190048038A1 (en) | 2016-02-23 | 2019-02-14 | Dana-Farber Cancer Institute, Inc. | Method for generating cell-penetrating stapled peptides that lack nonspecific membrane-lytic properties for therapeutic targeting |
| WO2018089648A2 (en) | 2016-11-09 | 2018-05-17 | Ohio State Innovation Foundation | Di-sulfide containing cell penetrating peptides and methods of making and using thereof |
| US20190309020A1 (en) | 2016-11-22 | 2019-10-10 | Ohio State Innovation Foundation | Cell-penetrating peptide sequences |
| TW202500573A (zh) | 2016-11-22 | 2025-01-01 | 俄亥俄州立創新基金會 | 細胞穿透肽序列 |
| WO2019084528A1 (en) | 2017-10-27 | 2019-05-02 | Ohio State Innovation Foundation | POLYPEPTIDE CONJUGATES FOR INTRACELLULAR ADMINISTRATION OF STAPLED PEPTIDES |
-
2018
- 2018-10-28 WO PCT/US2018/057894 patent/WO2019084528A1/en not_active Ceased
- 2018-10-28 CA CA3080617A patent/CA3080617A1/en active Pending
- 2018-10-28 CN CN202311469512.8A patent/CN117567639A/zh active Pending
- 2018-10-28 US US16/759,600 patent/US11510991B2/en active Active
- 2018-10-28 CN CN201880070271.0A patent/CN111447941B/zh active Active
- 2018-10-28 JP JP2020543254A patent/JP7780253B2/ja active Active
- 2018-10-28 EP EP18870802.8A patent/EP3700548A4/en active Pending
-
2022
- 2022-08-05 US US17/817,836 patent/US12115224B2/en active Active
-
2023
- 2023-07-14 JP JP2023115915A patent/JP2023134675A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021501201A5 (cg-RX-API-DMAC7.html) | ||
| DE69020143T2 (de) | Verfahren zur verwendung und herstellung von peptiden. | |
| DE69333397T2 (de) | Retro-, inverso-, und retro-inverso synthetische peptidanaloge | |
| Asahina et al. | Chemical synthesis of O‐glycosylated human interleukin‐2 by the reverse polarity protection strategy | |
| DE4434551A1 (de) | Peptide aus der Sequenz des hPTH (1-37) | |
| SA518391996B1 (ar) | نظائر عامل النمو الجلدي شبيه مجال أ ببدائل حمض دهني | |
| EP2829549A3 (en) | Hybrid and tandem expression of neisserial derived proteins | |
| JPS61502839A (ja) | ミモトープを検出または決定する方法 | |
| DE602004009710T2 (de) | Verfahren zur peptidsynthese unter verwendung einer reduzierten menge an entschützungsmittel | |
| WO2021092075A1 (en) | IL-2RβγC BINDING COMPOUNDS | |
| Kitas et al. | Fmoc-polyamide solid phase synthesis of an O-phosphotyrosine-containing tridecapeptide | |
| JP2015504893A5 (cg-RX-API-DMAC7.html) | ||
| DE896583T1 (de) | Neue osp-c abgeleitete peptidefragmente | |
| DE69223250T2 (de) | Detektion des immunschwäche-virus aus felis | |
| JP2016520529A5 (cg-RX-API-DMAC7.html) | ||
| CA1282550C (en) | Methods and compositions for preparation of h-arg-x-z-y-tyr-r | |
| DE69114339T2 (de) | Verfahren zur Identifizierung oder Bestimmung von Proteinen und Verwendungen dazu. | |
| ATE172983T1 (de) | Peptidfragmente des env-proteins vom immunschwäche-virus der katze und ihre verwendung in der diagnostik | |
| DE69915160T2 (de) | Verfahren zur Herstellung des Somatostatin Analogons Octreotide | |
| DE69530380T2 (de) | Retropeptide, antikörper dagegen und deren verwendungen in der impfung und in vitro diagnostik | |
| DE68905552T2 (de) | Immunostimulierende peptide, deren verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
| DE3400434A1 (de) | Bestimmung von fibrin mit fibrin-spezifischen antikoerpern | |
| WO1995020764A1 (de) | Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine | |
| DE68927854T2 (de) | Insulinomimetrische eigenschaften und insulin-rezeptor-bindestellen-peptide | |
| ATE294816T1 (de) | Neue, physiologisch aktive peptide und ihre verwendung. |